For years, cocoa-free chocolate was a curiosity — a vegan-adjacent novelty that tasted "close enough" and convinced almost no one. In 2026 it stopped being a gimmick and became a supply-chain strategy. The signal is not the startups; it is who is now standing behind them. Mars has moved into cocoa-free chocolate using Planet A Foods' ChoViva, Cargill is funding Voyage Foods, and Nestlé, Mondelēz and Barry Callebaut have all begun launching cocoa-free products. When the companies that own the chocolate aisle start hedging away from cocoa, buyers should ask why — and the answer runs straight through everything we have written about cocoa's structural fragility.
#What "cocoa-free" actually means
The category is not one technology; it is three, at very different stages of maturity, and confusing them is the first mistake a buyer can make.
The first and most advanced route is fermentation and reverse-engineering — recreating chocolate's flavour from cheaper, deforestation-free plant ingredients. Planet A Foods' ChoViva is built from fermented and roasted ingredients such as sunflower seeds and oats; Voyage Foods reverse-engineers a cocoa-like paste from sunflower kernels and grape seeds; others such as Nukoko and WNWN work from legumes and carob. These are commercial today.
The second route is cell-cultured cacao — growing real cocoa cells in bioreactors, no farm required, pursued by players like Kokomodo. It is genuinely "cocoa" at a molecular level but years from scale and cost parity.
The third, often lumped in but distinct, is cocoa-butter alternatives (CBEs and replacers) from ingredient majors — a fats play that reduces cocoa butter exposure rather than replacing chocolate outright.
For procurement, the taxonomy matters: a fermented sunflower bar, a bioreactor cocoa cell, and a cocoa-butter equivalent solve different problems and carry different risks.
#Why now: the economics finally flipped
Alternatives did not suddenly get better; cocoa got worse. At $2,500 a tonne, a reverse-engineered bar could not compete. After cocoa spiked toward $12,900 in 2024 and settled into a volatile $4,000–5,000 range, the cost equation inverted — and an ingredient with a stable, contractible price became strategically valuable almost regardless of taste parity. Three forces stack on top of that price signal: EUDR, which alternatives sidestep entirely because there is no deforestation risk to trace; carbon, with Planet A claiming roughly 80% less footprint than conventional chocolate; and supply security in a crop concentrated in two politically and biologically exposed countries. That combination is why the capital arrived — Planet A raised $30 million to scale from 2,000 to 15,000 tonnes a year and now has a global partnership with Barry Callebaut, while Cargill put its weight behind Voyage.
#The strategic read for procurement
Treat cocoa-free not as a replacement but as diversification — a second source in a supply base that has proven dangerously concentrated. Its natural home today is fillings, coatings, compound chocolate, and inclusions, where flavour tolerance is higher, not fine single-origin tablets, where it still falls short. Two constraints belong on every buyer's checklist. First, labelling: in the EU and US, "chocolate" is a legally defined term that requires cocoa, so these products cannot be sold as chocolate — they are "cocoa-free confections," and that framing shapes consumer acceptance. Second, maturity: fermentation-based products are shipping at scale; cell-cultured cacao is a bet on the next decade, not this budget cycle.
The real question is whether this is a durable structural shift or a spike-driven bubble that deflates if cocoa normalises. The honest answer is both, partially — but the direction of travel is what matters. Even if alternatives capture only a low single-digit share of a global chocolate market worth well over $100 billion, that is a permanent slice of demand removed from cocoa. And demand destruction is not neutral: it quietly caps cocoa's ceiling, feeding back into the price story and shifting pricing power. The majors are not betting cocoa disappears; they are buying an option on not being fully exposed to it — which is exactly what a hedge is.
For a procurement team, the move is to run alternatives as a live workstream now: qualify one or two suppliers, map which of your SKUs can tolerate a cocoa-free or partial-substitution formulation, and price the option before the next cocoa spike forces the decision under duress. The manufacturers treating this as strategy rather than novelty are the ones who will have a lever the next time West Africa's supply wobbles.
Cookiedogs tracks the demand side of cocoa as closely as the supply side — reformulation, substitution and the alternatives pipeline are signals that reshape price and risk, not sidebars to it. Reading both is how buyers stay ahead of the next move.
Informational market and supply-chain analysis, not trading, investment or legal advice.
